Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JCBio is a South Korean life science company that supplies research instruments, reagents, sequencing platforms, cell analysis systems, and related technical support to domestic biotech and biomedical researchers. Founded in 2005, the company appears to operate primarily as a distributor and commercialization partner for global life science tool makers rather than as a therapeutic drug developer. Its portfolio spans genomics, proteomics, cell analysis, spatial biology, flow and imaging platforms, and laboratory support services, and it has highlighted partnerships with companies such as Oxford Nanopore, MGI, Revvity, and others. JCBio also maintains a GMP-labeled branch office and a corporate research institute, suggesting in-house technical and application capabilities in addition to sales and service. Overall, the company is best characterized as an active commercial life science tools and research infrastructure company serving the Korean market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on JCBio.